These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 34678663
1. Establishment of a human-induced pluripotent stem cell line, KSCBi014-A, from a long QT syndrome type 2 patient harboring a KCNH2 mutation. Lee Y, Koo SK, Kim JH. Stem Cell Res; 2021 Dec; 57():102570. PubMed ID: 34678663 [Abstract] [Full Text] [Related]
5. Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant. Ge N, Liu M, Krawczyk J, McInerney V, Ward D, Shen S, O'Brien T, Prendiville T. Stem Cell Res; 2020 Dec; 49():101997. PubMed ID: 33002718 [Abstract] [Full Text] [Related]
6. Establishment of human embryonic stem cell WAe009-A-88 carrying a long QT syndrome mutation in KCNH2. Wen H, Sun L, Zhong J, Wu F. Stem Cell Res; 2022 Jul; 62():102795. PubMed ID: 35526388 [Abstract] [Full Text] [Related]
7. Establishment of human embryonic stem cell WAe009-A-74 carrying a Long QT syndrome mutation in KCNH2. Sun L, Zhong J, Wu F, Li F, Yang X, Zeng Z. Stem Cell Res; 2022 Apr; 60():102725. PubMed ID: 35247842 [Abstract] [Full Text] [Related]
8. Establishment of two human induced pluripotent stem cell lines from familial long QT syndrome type 1 patients carrying KCNQ1 mutation. Mun D, Yoo G, Park M, Kang JY, Yun N, Joung B. Stem Cell Res; 2024 Dec; 81():103571. PubMed ID: 39388802 [Abstract] [Full Text] [Related]
9. Establishment of a human induced pluripotent stem cell line, KSCBi015-A, from a long QT syndrome type 1 patient harboring a KCNQ1 mutation. Lee Y, Park H, Kyung Koo S, Kim JH. Stem Cell Res; 2021 Oct; 56():102521. PubMed ID: 34509919 [Abstract] [Full Text] [Related]
10. Reprogramming of a human induced pluripotent stem cell line from a long QT syndrome patient harboring a heterozygous mutation of c.1537C > T in SCN5A gene. Chen J, Song Y, Gu J, Chen L. Stem Cell Res; 2021 Dec; 57():102576. PubMed ID: 34678660 [Abstract] [Full Text] [Related]
11. Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant. Goual L, Bounasri E, Vincenti M, Amédro P, Desprat R, Bernex F, Lemaitre JM, Pasquié JL, Lacampagne A, Thireau J, Meli AC. Stem Cell Res; 2023 Oct; 72():103192. PubMed ID: 37660555 [Abstract] [Full Text] [Related]
14. Generation of a human embryonic stem cell line (WAe009-A-43) carrying a Long QT syndrome related mutation in KCNH2 gene. Wu X, Zhao Y, Wang X. Stem Cell Res; 2020 Oct; 48():101976. PubMed ID: 32911324 [Abstract] [Full Text] [Related]
16. Injectable contraceptive Depo-Provera induces erratic beating patterns in patient-specific induced pluripotent stem cell-derived cardiomyocytes with long QT syndrome type 2. Pinsky AM, Gao X, Bains S, Kim CJ, Louradour J, Odening KE, Tester DJ, Giudicessi JR, Ackerman MJ. Heart Rhythm; 2023 Jun; 20(6):910-917. PubMed ID: 36889623 [Abstract] [Full Text] [Related]
17. Reprogramming of a human induced pluripotent stem cell line from a Marfan syndrome patient harboring a heterozygous mutation of c.2939G > A in FBN1 gene. Qin Z, Sun L, Sun X, Gao X, Su H. Stem Cell Res; 2021 Mar; 51():102163. PubMed ID: 33450697 [Abstract] [Full Text] [Related]
19. Reprogramming of a human induced pluripotent stem cell line (ZZUSAHi004-A) from a long QT syndrome patient with a heterozygous AKAP9 (c. 4021C > A) mutant. Ding T, Zhu W, Li X, Jian L. Stem Cell Res; 2022 Dec; 65():102966. PubMed ID: 36395689 [Abstract] [Full Text] [Related]